Author: Ortolan, Augusta; Lorenzin, Mariagrazia; Felicetti, Mara; Doria, Andrea; Ramonda, Roberta
Title: Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis Cord-id: hkk58byo Document date: 2020_8_12
ID: hkk58byo
Snippet: Abstract Background Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV) has been recently characterized, and soon spread around the world generating a pandemic. It has been suggested that men are more severely affected by the viral disease (COVID-19) than women. Objective the aim of the present Systematic Literature Review (SRL) and meta-analysis was to analyse the influence of gender on COVID-19 mortality, severity and disease outcomes. A SRL was performed in PubMed and Embase searching
Document: Abstract Background Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV) has been recently characterized, and soon spread around the world generating a pandemic. It has been suggested that men are more severely affected by the viral disease (COVID-19) than women. Objective the aim of the present Systematic Literature Review (SRL) and meta-analysis was to analyse the influence of gender on COVID-19 mortality, severity and disease outcomes. A SRL was performed in PubMed and Embase searching terms corresponding to the “PEO†format (Population = adult patients affected with COVID-19, Exposure = gender; Outcome = any available clinical outcomes by gender, including mortality and disease severity), search dates 01/01/2020-31/04/2020. Exclusion criteria were: case reports/series, reviews, commentaries, language other than English. We included full-text original articles. Data about study type, country, patients characteristics were extracted. Study quality was evaluated by Newcastle-Ottawa Scale (NOS). From a total of 950 hits generated by databases search, 85 articles fulfilling inclusion/exclusion criteria were selected. Results A random-effect meta-analysis was performed to compare mortality, recovery rates and disease severity in men versus women. Male to female ratio was 1: 0.8. A significant association between male sex and mortality (OR = 1.81; 95%CI: 1.25-2.62), as well as a lower chance of recovery in men (OR = 0.72; 95% CI: 0.55- 0.95). Male patients had a higher odd to present with a severe form of COVID-19 (OR = 1.46; 95%CI: 1.10-1.94). Conclusions male are more susceptible to COVID-19 infection, present with a more severe disease and have a worse prognosis. Further studies are warranted to unravel biological mechanisms underlying these observations.
Search related documents:
Co phrase search for related documents- abstract title and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- abstract title and longitudinal study: 1, 2, 3, 4
- abstract title and lopinavir ritonavir: 1, 2
- abstract title and low number: 1, 2, 3
- abstract title and low production: 1
- abstract title and lower grade: 1
- acute respiratory syndrome and long hospital stay: 1, 2, 3
- acute respiratory syndrome and longitudinal cohort: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
- acute respiratory syndrome and longitudinal cohort design: 1, 2, 3, 4, 5, 6, 7
- acute respiratory syndrome and longitudinal study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acute respiratory syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- acute respiratory syndrome and low number: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62
- acute respiratory syndrome and low production: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- acute respiratory syndrome and low recovery rate: 1, 2
- acute respiratory syndrome and lower grade: 1, 2, 3, 4
- acute respiratory syndrome coronavirus and long hospital stay: 1, 2
- acute respiratory syndrome coronavirus and longitudinal cohort: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- acute respiratory syndrome coronavirus and longitudinal cohort design: 1, 2, 3, 4, 5
- acute respiratory syndrome coronavirus and longitudinal study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67
Co phrase search for related documents, hyperlinks ordered by date